New Delhi: India's total tally of COVID-19 cases crossed the 1.50-crore mark with around 25 lakh cases being added in just 15 days, while active cases surpassed the 19-lakh mark, according to the Union Health Ministry data updated on Monday.
The nationwide tally of COVID-19 cases mounted to 1,50,61,919 with a record single-day rise of 2,73,810 coronavirus infections.
The death toll increased to 1,78,769 with a record 1,619 daily new fatalities, the data updated at 8 a.m showed.
The country's total COVID-19 infections had surpassed the one-crore mark on December 19 after which it took 107 days to cross the 1.25 crore on April 5. However, it only took 15 days for the cases to cross the 1.50-crore mark.
Registering a steady increase for the 40th day in a row, the active cases increased to 19,29,329, comprising 12.81% of the total infections, while the national COVID-19 recovery rate has dropped to 86%.
The number of people who have recuperated from the disease surged to 1,29,53,821 and the case fatality rate has further dropped to 1.19%, the data stated.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.
According to the ICMR, 26,78,94,549 samples have been tested up to April 18 with 13,56,133 samples being tested on Sunday.
The 1,619 new fatalities include 503 from Maharashtra, 170 from Chhattisgarh, 161 from Delhi, 127 from Uttar Pradesh, 110 from Gujarat, 81 from Karnataka, 68 from Punjab, 66 from Madhya Pradesh, 50 from Jharkhand, 42 each from Rajasthan and Tamil Nadu, 29 from Haryana, 28 from West Bengal and 25 from Kerala.
A total of 1,78,769 deaths have been reported so far in the country including 60,473 from Maharashtra, 13,351 from Karnataka, 13,113 from Tamil Nadu, 12,121 from Delhi, 10,568 from West Bengal, 9,830 from Uttar Pradesh, 7,902 from Punjab and 7,410 from Andhra Pradesh.
Delhi Govt Control Rooms to Manage COVID Drugs
The Delhi government has set up two control rooms to monitor and manage the supply of "COVID-19 management drugs" amid a massive rise in coronavirus cases in the national capital.
Delhi on Sunday recorded the biggest jump in its daily COVID-19 tally with 25,462 fresh cases, while the positivity rate shot up to 29.74 per cent -- meaning almost every third sample being tested in the city is turning out to be positive.
In an order, the government's Drugs Control Department said that the step has been taken to address reports of "acute shortage of COVID-19 management drugs due to a sudden rise in COVID-19 cases in Delhi".
"In view to counter this situation and to facilitate the general public at large, the Drugs Control Department. Govt of NCT of Delhi has set up two control rooms," the order dated April 13 said.
For East, North East, South, Central, New Delhi and North districts, the Karkardooma Head Office will serve as the control room and operate the helpline number -- 011-22393705, according to the order.
The Lawrence Road Zonal Office is the second control room and it will serve the North West, South West, and West districts. It can be reached at helpline number-- 011-27100164, it said.
Delhi Officers to Monitor Oxygen, Remdesivir Sale
The Delhi government on Monday deployed two teams of officers to monitor procurement and supply of oxygen and the Remdesivir drug amid a shortage of both following an exponential rise in COVID-19 cases here.
According to an official order issued by the health department, a team of nine officers will be deputed at oxygen filling plants, and oversee operations of medical oxygen suppliers.
"The officers will oversee the entire procurement process of medical oxygen by the filler agency and ensure that the quantity of oxygen procured is properly entered in the dedicated register," it said.
"The team will oversee distribution of medical oxygen to various hospitals and nursing homes in Delhi. Each officer shall submit a report on a daily basis to the Officer on Special Duty," the order said.
Through a separate order, the Delhi government also deputed 28 drug inspectors to monitor the movement of Remdesivir injections in the national capital on a daily basis.
"The drug inspectors shall oversee the whole procurement process of Remdesivir injection starting from placement of order and its receipt by distributor or dealer from company," it stated.
The team will ensure that all supplies received by distributors and dealers are entered in their relevant records and all inventories are properly accounted, the order said.